Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Catabasis Pharma (NQ: CATB )

2.810 USD -0.060 (-2.09%)
Official Closing Price Updated: 7:34 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Catabasis Pharma

< Previous 1 2 3 4 5 6 Next >
Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences. 
From Business Wire News Releases
Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.
Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc. 
From Business Wire News Releases
Development of Advanced Novel AML Drugs Target Increasing Cases of Acute Myeloid Leukemia
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Development of Advanced Novel AML Drugs Target Increasing Cases of Acute Myeloid Leukemia
Financialnewsmedia.com News Commentary 
From PR Newswire
Catabasis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
Catabasis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides a Corporate Update 
From Business Wire News Releases
Catabasis Pharmaceuticals Announces Top-Line Results for the Phase 3 PolarisDMD Trial of Edasalonexent in Duchenne Muscular Dystrophy
Catabasis Pharmaceuticals Announces Top-Line Results for the Phase 3 PolarisDMD Trial of Edasalonexent in Duchenne Muscular Dystrophy 
From Business Wire News Releases
Catabasis Pharmaceuticals Presents Information on Edasalonexent, a Potential Foundational Therapy for Duchenne Muscular Dystrophy, at the Virtual 25th International Congress of the World Muscle Societ
Catabasis Presents Information on Edasalonexent at the Virtual 25th International Congress of the World Muscle Society 
From Business Wire News Releases
Catabasis Pharmaceuticals to Present During the Virtual 25th International Congress of the World Muscle Society
Catabasis Pharmaceuticals to Present During the Virtual 25th International Congress of the World Muscle Society 
From Business Wire News Releases
Catabasis Pharmaceuticals Names Noah Clauser Chief Financial Officer
Catabasis Pharmaceuticals Names Noah Clauser Chief Financial Officer 
From Business Wire News Releases
Catabasis Pharmaceuticals to Present at Upcoming Virtual Investor Conferences
Catabasis Pharmaceuticals to Present at Upcoming Virtual Investor Conferences 
From Business Wire News Releases
Catabasis Pharmaceuticals to Host Virtual KOL Event on Edasalonexent and Duchenne Muscular Dystrophy
Catabasis Pharmaceuticals to Host Virtual KOL Event on Edasalonexent and Duchenne Muscular Dystrophy 
From Business Wire News Releases
Thinking about trading options or stock in CryoPort Inc, Catabasis Pharmaceuticals Inc, Wayfair, Novavax, Inc., or Thermo Fisher Scientific Inc.?
InvestorsObserver issues critical PriceWatch Alerts for CYRX, CATB, W, NVAX, and TMO. 
From PR Newswire
Catabasis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Reviews Business Progress
Catabasis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Reviews Business Progress 
From Business Wire News Releases
Catabasis Pharmaceuticals to Present at Virtual 2020 Wedbush PacGrow Healthcare Conference
Catabasis Pharmaceuticals to Present at Virtual 2020 Wedbush PacGrow Healthcare Conference 
From Business Wire News Releases
Catabasis Pharmaceuticals and Bill & Melinda Gates Medical Research Institute to Study CAT-5571 in Drug-Sensitive and Drug-Resistant Tuberculosis
Catabasis Pharmaceuticals and Bill & Melinda Gates Medical Research Institute to Study CAT-5571 in Drug-Sensitive and Drug-Resistant Tuberculosis 
From Business Wire News Releases
Catabasis Pharmaceuticals to Report Second Quarter 2020 Financial Results on Monday, August 10th
Catabasis Pharmaceuticals to Report Second Quarter 2020 Financial Results on Monday, August 10th 
From Business Wire News Releases
Catabasis Pharmaceuticals to Present at Parent Project Muscular Dystrophy Virtual Annual Conference
Catabasis Pharmaceuticals to Present at Parent Project Muscular Dystrophy Virtual Annual Conference 
From Business Wire News Releases
Catabasis Joins Russell 3000® Index
Catabasis Joins Russell 2000® Index 
From Business Wire News Releases
Catabasis Pharmaceuticals Names Ben Harshbarger Senior Vice President, General Counsel
Catabasis Pharmaceuticals Names Ben Harshbarger Senior Vice President, General Counsel 
From Business Wire News Releases
Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business Progress
Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business Progress 
From Business Wire News Releases
Catabasis Pharmaceuticals Presents Edasalonexent, a Potential Foundational Therapy for Duchenne Muscular Dystrophy
Catabasis Pharmaceuticals Presents Edasalonexent, a Potential Foundational Therapy for Duchenne Muscular Dystrophy 
From Business Wire News Releases
Catabasis Pharmaceuticals to Report First Quarter 2020 Financial Results on Tuesday, May 12th
Catabasis Pharmaceuticals to Report First Quarter 2020 Financial Results on Tuesday, May 12th 
From Business Wire News Releases
Catabasis Pharmaceuticals to Present at 2020 Muscular Dystrophy Association Virtual Poster Session
Catabasis Pharmaceuticals to Present at 2020 Muscular Dystrophy Association Virtual Poster Session 
From Business Wire News Releases
Solebury Trout Announces Additional Virtual Conference Presentations from Life Science Companies on April 7, 2020
From ACCESSWIRE
Catabasis Pharmaceuticals to Present at the Upcoming 2020 Solebury Trout Virtual Investor Conference
Catabasis Pharmaceuticals to Present at the Upcoming 2020 Solebury Trout Virtual Investor Conference. 
From Business Wire News Releases
Solebury Trout Announces Virtual Conference Series with Presentations from Life Science Companies
From ACCESSWIRE
Catabasis Pharmaceuticals to Present During the Muscular Dystrophy Association Virtual Clinical Trials Session
Catabasis Pharmaceuticals to Present During the Muscular Dystrophy Association Virtual Clinical Trials Session 
From Business Wire News Releases
Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Reviews Business Progress
Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Reviews Business Progress 
From Business Wire News Releases
Catabasis Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results and Recent Corporate Developments on Tuesday, March 10th
Catabasis Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results and Recent Corporate Developments on Tuesday, March 10th 
From Business Wire News Releases
Catabasis Pharmaceuticals to Present Edasalonexent at the XVIII International Conference on Duchenne and Becker Muscular Dystrophy
Catabasis Pharmaceuticals to present edasalonexent at the XVIII International Conference on Duchenne and Becker Muscular Dystrophy 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.